Kayla D Isbell1, Shuyan Wei1, Shah-Jahan M Dodwad1, Elenir Bc Avritscher2, Krislynn M Mueck1, Karla Bernardi1, Gabrielle E Hatton1, Mike K Liang3, Tien C Ko4, Lillian S Kao5. 1. Department of Surgery; Center for Surgical Trials and Evidence-based Practice. 2. Center for Clinical Research and Evidence-Based Medicine, McGovern Medical School at the University of Texas Health Science Center, Houston, TX. 3. University of Houston, HCA Healthcare Kingwood, Kingwood, TX. 4. Department of Surgery. 5. Department of Surgery; Center for Surgical Trials and Evidence-based Practice; Center for Clinical Research and Evidence-Based Medicine, McGovern Medical School at the University of Texas Health Science Center, Houston, TX. Electronic address: Lillian.S.Kao@uth.tmc.edu.
Abstract
BACKGROUND: The Gallstone Pancreatitis: Admission vs Normal Cholecystectomy (Gallstone PANC) Trial demonstrated that cholecystectomy within 24 hours of admission (early) compared with after clinical resolution (control) for mild gallstone pancreatitis, significantly reduced 30-day length-of-stay (LOS) without increasing major postoperative complications. We assessed whether early cholecystectomy decreased 90-day healthcare use and costs. STUDY DESIGN: A secondary economic evaluation of the Gallstone PANC Trial was performed from the healthcare system perspective. Costs for index admissions and all gallstone pancreatitis-related care 90 days post-discharge were obtained from the hospital accounting system and inflated to 2020 USD. Negative binomial regression models and generalized linear models with log-link and gamma distribution, adjusting for randomization strata, were used. Bayesian analysis with neutral prior was used to estimate the probability of cost reduction with early cholecystectomy. RESULTS: Of 98 randomized patients, 97 were included in the analyses. Baseline characteristics were similar in early (n = 49) and control (n = 48) groups. Early cholecystectomy resulted in a mean absolute difference in LOS of -0.96 days (95% CI, -1.91 to 0.00, p = 0.05). Ninety-day mean total costs were $14,974 (early) vs $16,190 (control) (cost ratio [CR], 0.92; 95% CI, 0.73-1.15, p = 0.47), with a mean absolute difference of $1,216 less (95% CI, -$4,782 to $2,349, p = 0.50) per patient in the early group. On Bayesian analysis, there was an 81% posterior probability that early cholecystectomy reduced 90-day total costs. CONCLUSION: In this single-center trial, early cholecystectomy for mild gallstone pancreatitis reduced 90-day LOS and had an 81% probability of reducing 90-day healthcare system costs.
BACKGROUND: The Gallstone Pancreatitis: Admission vs Normal Cholecystectomy (Gallstone PANC) Trial demonstrated that cholecystectomy within 24 hours of admission (early) compared with after clinical resolution (control) for mild gallstone pancreatitis, significantly reduced 30-day length-of-stay (LOS) without increasing major postoperative complications. We assessed whether early cholecystectomy decreased 90-day healthcare use and costs. STUDY DESIGN: A secondary economic evaluation of the Gallstone PANC Trial was performed from the healthcare system perspective. Costs for index admissions and all gallstone pancreatitis-related care 90 days post-discharge were obtained from the hospital accounting system and inflated to 2020 USD. Negative binomial regression models and generalized linear models with log-link and gamma distribution, adjusting for randomization strata, were used. Bayesian analysis with neutral prior was used to estimate the probability of cost reduction with early cholecystectomy. RESULTS: Of 98 randomized patients, 97 were included in the analyses. Baseline characteristics were similar in early (n = 49) and control (n = 48) groups. Early cholecystectomy resulted in a mean absolute difference in LOS of -0.96 days (95% CI, -1.91 to 0.00, p = 0.05). Ninety-day mean total costs were $14,974 (early) vs $16,190 (control) (cost ratio [CR], 0.92; 95% CI, 0.73-1.15, p = 0.47), with a mean absolute difference of $1,216 less (95% CI, -$4,782 to $2,349, p = 0.50) per patient in the early group. On Bayesian analysis, there was an 81% posterior probability that early cholecystectomy reduced 90-day total costs. CONCLUSION: In this single-center trial, early cholecystectomy for mild gallstone pancreatitis reduced 90-day LOS and had an 81% probability of reducing 90-day healthcare system costs.
Authors: Francisco Riquelme; Boris Marinkovic; Marco Salazar; Waldo Martínez; Felipe Catan; Sebastián Uribe-Echevarría; Felipe Puelma; Jorge Muñoz; Andrea Canals; Cristian Astudillo; Mario Uribe Journal: HPB (Oxford) Date: 2019-06-22 Impact factor: 3.647
Authors: James L Buxbaum; Syed M Abbas Fehmi; Shahnaz Sultan; Douglas S Fishman; Bashar J Qumseya; Victoria K Cortessis; Hannah Schilperoort; Lynn Kysh; Lea Matsuoka; Patrick Yachimski; Deepak Agrawal; Suryakanth R Gurudu; Laith H Jamil; Terry L Jue; Mouen A Khashab; Joanna K Law; Jeffrey K Lee; Mariam Naveed; Mandeep S Sawhney; Nirav Thosani; Julie Yang; Sachin B Wani Journal: Gastrointest Endosc Date: 2019-04-09 Impact factor: 9.427
Authors: Peter J Fagenholz; Carlos Fernández-del Castillo; N Stuart Harris; Andrea J Pelletier; Carlos A Camargo Journal: Pancreas Date: 2007-11 Impact factor: 3.327
Authors: Armen Aboulian; Tony Chan; Arezou Yaghoubian; Amy H Kaji; Brant Putnam; Angela Neville; Bruce E Stabile; Christian de Virgilio Journal: Ann Surg Date: 2010-04 Impact factor: 12.969
Authors: Krislynn M Mueck; Shuyan Wei; Claudia Pedroza; Karla Bernardi; Margaret L Jackson; Mike K Liang; Tien C Ko; Jon E Tyson; Lillian S Kao Journal: Ann Surg Date: 2019-09 Impact factor: 12.969